Patents by Inventor Dan G. Duda

Dan G. Duda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triple Negative Breast Cancer Treatment Method
    Publication number: 20240148714
    Abstract: Disclosed is a method of treating triple negative breast cancer in a human patient, comprising administering to the patient an amount of cabozantinib or a pharmaceutically acceptable salt thereof, wherein the amount of cabozantinib is sufficient to activate the immune system.
    Type: Application
    Filed: October 19, 2023
    Publication date: May 9, 2024
    Inventors: Sara M. Tolaney, Dan G. Duda
  • Triple Negative Breast Cancer Treatment Method
    Publication number: 20210030737
    Abstract: Disclosed is a method of treating triple negative breast cancer in a human patient, comprising administering to the patient an amount of cabozantinib or a pharmaceutically acceptable salt thereof, wherein the amount of cabozantinib is sufficient to activate the immune system.
    Type: Application
    Filed: April 18, 2017
    Publication date: February 4, 2021
    Applicant: Exelixis, Inc.
    Inventors: Sara M. TOLANEY, Dan G. DUDA
  • ANTI-CXCR4 AS A SENSITIZER TO CANCER THERAPEUTICS
    Publication number: 20160128974
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Application
    Filed: September 1, 2015
    Publication date: May 12, 2016
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura
  • Anti-CXCR4 as a sensitizer to cancer therapeutics
    Patent number: 9155723
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: October 13, 2015
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura
  • ANTI-CXCR4 AS A SENSITIZER TO CANCER THERAPEUTICS
    Publication number: 20130216531
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 22, 2013
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura